The Pan-Deacetylase Inhibitor Panobinostat Downregulates HIF-1α and VEGF and, Synergizes With Everolimus In Hodgkin Lymphoma Cell Lines

被引：4
|
作者：
Lemoine, Manuela [1 ]
Buglio, Daniela [1 ]
Jona, Adam [1 ]
Derenzini, Enrico [1 ]
Medeiros, L. Jeffrey [2 ]
Berry, Donald A. [3 ]
Younes, Anas [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Heniatopathol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
10.1182/blood.V116.21.2851.2851
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1174 / 1175
页数：2
相关论文
共 39 条
  • [21] Hypoxic induction of HIF-1α and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases
    Shemirani, B
    Crowe, DL
    ORAL ONCOLOGY, 2002, 38 (03) : 251 - 257
  • [22] PCI-24781, a novel histone deacetylase inhibitor (HDACI), induces caspase-dependent apoptosis in Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) cell lines and is synergistic in combination with bortezomib
    Bhalla, S.
    David, K.
    Balasubramanian, S.
    Prachand, S.
    Mauro, L.
    Sirisawad, M.
    Buggy, J.
    Miller, R. A.
    Gordon, L. I.
    Evens, A. M.
    ANNALS OF ONCOLOGY, 2008, 19 : 161 - 161
  • [23] GLYCOLYTIC INHIBITOR 2-DEOXY-GLUCOSE SUPPRESSES CELL PROLIFERATION IN NON-HODGKIN LYMPHOMA CELLS THROUGH DOWN-REGULATION OF HIF-1 AND C-MYC
    Wang, T.
    Pang, Y.
    Chen, F.
    Huang, H.
    Xiao, F.
    Zhong, J.
    Zhong, H.
    HAEMATOLOGICA, 2015, 100 : 553 - 553
  • [24] Histone deacetylase inhibitor (HDACi) PCI-24781 and bortezomib result in synergistic apoptosis in Hodgkin lymphoma (HL) and non-Hodgkin's lymphoma (NHL) cell lines: Investigation of cell death and NFKB-Mediated pathways
    Bhalla, Savita
    David, Kevin
    Mauro, Lauren
    Prachand, Sheila
    Sirisawad, Mint
    Balasubramanian, Sriram
    Miller, Richard A.
    Buggy, Joseph
    Gordon, Leo I.
    Evens, Andrew M.
    BLOOD, 2007, 110 (11) : 1050A - 1050A
  • [25] Targeted Repression of Overexpressed CD30 Downregulates NF-κB and ERK1/2 Pathway in Hodgkin Lymphoma Cell Lines
    Watanabe, Mariko
    Nakano, Kazumi
    Togano, Tomiteru
    Nakashima, Makoto
    Higashihara, Masaaki
    Kadin, Marshall E.
    Watanabe, Toshiki
    Horie, Ryouichi
    ONCOLOGY RESEARCH, 2011, 19 (10-11) : 463 - 469
  • [26] HIF-1α Induces a Chemoresistance Phenotype in a Non-Hodgkin's Lymphoma Cell Line Via up-Regulation of Bel-xL
    Hernandez-Luna, Marco A.
    Rocha-Zavaleta, Leticia
    Vega, Mario I.
    Huerta-Yepez, Sara
    BLOOD, 2012, 120 (21)
  • [27] The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism
    Buglio, Daniela
    Mamidipudi, Vidya
    Khaskhely, Noor M.
    Brady, Helen
    Heise, Carla
    Besterman, Jeffrey
    Martell, Robert E.
    MacBeth, Kyle
    Younes, Anas
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (04) : 387 - 396
  • [28] Glycolytic inhibitor 2-deoxy-D-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC
    Pang, Yu-Yang
    Wang, Ting
    Chen, Fang-Yuan
    Wu, Ying-Li
    Shao, Xia
    Xiao, Fei
    Huang, Hong-Hui
    Zhong, Hua
    Zhong, Ji-Hua
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1821 - 1830
  • [29] Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines
    Tyszka-Czochara, Malgorzata
    Bukowska-Strakova, Karolina
    Kocemba-Pilarczyk, Kinga A.
    Majka, Marcin
    NUTRIENTS, 2018, 10 (07):
  • [30] Recombinant human erythropoietin accelerated the proliferation of non-small cell lung cancer cell lines and reduced the expression of VEGF, HIF-1α, and PD-L1 under a simulated hypoxic environment in vitro
    Zhang Yajing
    Feng Yangchun
    Sun Xiaojie
    慢性疾病与转化医学（英文）, 2022, 08 (02) : 124 - 133
1234